ATE276266T1 - Nukleinsäureliganden für gewebeziele - Google Patents

Nukleinsäureliganden für gewebeziele

Info

Publication number
ATE276266T1
ATE276266T1 AT96915422T AT96915422T ATE276266T1 AT E276266 T1 ATE276266 T1 AT E276266T1 AT 96915422 T AT96915422 T AT 96915422T AT 96915422 T AT96915422 T AT 96915422T AT E276266 T1 ATE276266 T1 AT E276266T1
Authority
AT
Austria
Prior art keywords
nucleic acid
tissue targets
acid ligands
cells
ligands
Prior art date
Application number
AT96915422T
Other languages
English (en)
Inventor
Andrew Stephens
Daniel J Schneider
Larry Gold
Ulrich Speck
Original Assignee
Gilead Sciences Inc
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/433,124 external-priority patent/US5750342A/en
Priority claimed from US08/433,126 external-priority patent/US5688935A/en
Application filed by Gilead Sciences Inc, Schering Ag filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of ATE276266T1 publication Critical patent/ATE276266T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811Selection methods for production or design of target specific oligonucleotides or binding molecules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3222'-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/35Nature of the modification
    • C12N2310/351Conjugate
    • C12N2310/3517Marker; Tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • C12N2320/13Applications; Uses in screening processes in a process of directed evolution, e.g. SELEX, acquiring a new function
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)

Landscapes

  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96915422T 1995-05-03 1996-05-01 Nukleinsäureliganden für gewebeziele ATE276266T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/433,124 US5750342A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target
US08/433,126 US5688935A (en) 1990-06-11 1995-05-03 Nucleic acid ligands of tissue target
PCT/US1996/006059 WO1996034874A1 (en) 1995-05-03 1996-05-01 Nucleic acid ligands of tissue target

Publications (1)

Publication Number Publication Date
ATE276266T1 true ATE276266T1 (de) 2004-10-15

Family

ID=27029755

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04015822T ATE401424T1 (de) 1995-05-03 1996-05-01 Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele
AT96915422T ATE276266T1 (de) 1995-05-03 1996-05-01 Nukleinsäureliganden für gewebeziele

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04015822T ATE401424T1 (de) 1995-05-03 1996-05-01 Verfahren zur identifizierung von nukleinsäureliganden für gewebsziele

Country Status (9)

Country Link
EP (3) EP2000534A3 (de)
JP (1) JPH11504812A (de)
AT (2) ATE401424T1 (de)
AU (1) AU727460B2 (de)
CA (2) CA2641149A1 (de)
DE (2) DE69633386T2 (de)
DK (1) DK1564290T3 (de)
ES (1) ES2310695T3 (de)
WO (1) WO1996034874A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127119A (en) * 1990-06-11 2000-10-03 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands of tissue target
US6716580B2 (en) 1990-06-11 2004-04-06 Somalogic, Inc. Method for the automated generation of nucleic acid ligands
US6346611B1 (en) * 1990-06-11 2002-02-12 Gilead Sciences, Inc. High affinity TGfβ nucleic acid ligands and inhibitors
US6068829A (en) 1995-09-11 2000-05-30 The Burnham Institute Method of identifying molecules that home to a selected organ in vivo
US20070166741A1 (en) 1998-12-14 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US6232287B1 (en) 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
AU777823B2 (en) * 1999-01-19 2004-11-04 Somalogic, Inc. Method and apparatus for the automated generation of nucleic acid ligands
US7452964B2 (en) 2001-09-07 2008-11-18 Board Of Regents, The University Of Texas System Compositions and methods of use of targeting peptides against placenta and adipose tissues
US7420030B2 (en) 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040170955A1 (en) 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US8030465B2 (en) 2001-06-29 2011-10-04 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
AU2775402A (en) * 2001-06-29 2003-01-02 Medimolecular Pty Ltd Nucleic acid ligands to complex targets
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US7855054B2 (en) 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US8906700B2 (en) 2007-11-06 2014-12-09 Ambergen, Inc. Methods and compositions for phototransfer
EP2078751A1 (de) * 2008-01-11 2009-07-15 Commissariat A L'energie Atomique Spezifische zur Unterdrückung der Zellmigration und -invasion durch Krebszellen erzeugte Aptamere, Verfahren zur Auswahl derartiger Aptamere und ihre Verwendung
EP2159286A1 (de) * 2008-09-01 2010-03-03 Consiglio Nazionale Delle Ricerche Verfahren zur Gewinnung von Oligonucleotid-Aptameren und Verwendungen damit
KR102290214B1 (ko) 2013-11-21 2021-08-18 소마로직, 인크. 시티딘-5-카르복스아미드 변형된 뉴클레오티드 조성물 및 그와 관련된 방법들

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2259800T3 (es) 1990-06-11 2006-10-16 Gilead Sciences, Inc. Procedimientos de uso de ligandos de acido nucleico.
US5705337A (en) 1990-06-11 1998-01-06 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chemi-SELEX
US5270163A (en) 1990-06-11 1993-12-14 University Research Corporation Methods for identifying nucleic acid ligands
US5683867A (en) 1990-06-11 1997-11-04 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: blended SELEX
US5496938A (en) 1990-06-11 1996-03-05 Nexstar Pharmaceuticals, Inc. Nucleic acid ligands to HIV-RT and HIV-1 rev
US5637459A (en) 1990-06-11 1997-06-10 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: chimeric selex
JPH06508022A (ja) * 1991-02-21 1994-09-14 ギリアド サイエンシズ,インコーポレイテッド 生体分子に特異的なアプタマーおよび生産方法
WO1992014842A1 (en) * 1991-02-21 1992-09-03 Gilead Sciences, Inc. Aptamers specific for thrombin and methods of use
US5726014A (en) * 1991-06-27 1998-03-10 Genelabs Technologies, Inc. Screening assay for the detection of DNA-binding molecules
WO1994029479A1 (en) * 1993-06-09 1994-12-22 Pharmagenics, Inc. Oligonucleotides which inhibit hiv protease function
CA2219807C (en) * 1995-05-03 2008-12-30 Nexstar Pharmaceuticals, Inc. Systematic evolution of ligands by exponential enrichment: tissue selex
US20170110787A1 (en) 2015-10-14 2017-04-20 Apple Inc. Electronic Devices With Millimeter Wave Antennas And Metal Housings
US12393593B2 (en) 2023-09-12 2025-08-19 Optum, Inc. Priority-driven federated query-based data caching

Also Published As

Publication number Publication date
DK1564290T3 (da) 2008-11-17
ES2310695T3 (es) 2009-01-16
EP2000534A2 (de) 2008-12-10
EP1564290A2 (de) 2005-08-17
EP2000534A3 (de) 2009-09-02
ATE401424T1 (de) 2008-08-15
DE69633386D1 (de) 2004-10-21
EP0824540B1 (de) 2004-09-15
DE69633386T2 (de) 2005-09-22
EP0824540A4 (de) 2003-04-23
AU727460B2 (en) 2000-12-14
DE69637605D1 (de) 2008-08-28
CA2219106C (en) 2008-09-23
CA2641149A1 (en) 1996-11-07
EP0824540A1 (de) 1998-02-25
AU5720096A (en) 1996-11-21
CA2219106A1 (en) 1996-11-07
EP1564290B1 (de) 2008-07-16
WO1996034874A1 (en) 1996-11-07
JPH11504812A (ja) 1999-05-11
EP1564290A3 (de) 2006-02-01

Similar Documents

Publication Publication Date Title
ATE276266T1 (de) Nukleinsäureliganden für gewebeziele
DE69434942D1 (de) Mehrzweckreagenzsystem zur schnellen lysierung von vollblutproben
ATE466960T1 (de) Verwendung von nukleinsäureliganden in der durchflusszytometrie
CA2002868A1 (en) Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors
MX9100052A (es) Biblioteca(o conjunto)de bio-oligomeros al azar,un metodo de sintesis de los mismos y un metodo de uso de los mismos
BR8500963A (pt) Aparelho grampeador cirurgico,aparelho de acionamento para grampeador cirurgico,encadeamento acionador para operar acionador de grampeador cirurgico,encadeamento de quatro barras para operar acionador de grampo de grampeador cirurgico,processo para mover grampos cirurgicos,processo de distribuicao e formacao de grampos cirurgicos e processo de captacao de grampos cirurgicos
DE69940198D1 (de) Mikrovorrichtung zum screening von biomolekülen
DE69533564D1 (de) Effektor-Proteine für Rapamycin
DE68915258D1 (de) Verfahren zur katalytischen Oligomerisierung von Olefinen.
ES2160716T3 (es) Procedimiento para estabilizar la respuesta de un biosensor.
WO2001012659A3 (en) Human dna sequences
EP1153298A4 (de) Kombinatorische, komplexe kohlenhydrat-bibliotheken und verfahren zur herstellung und zum gebrauch davon
DE69903399D1 (de) Prepolymerisierte katalysatorkomponente für die polymerisierung von olefinen
WO1988007576A3 (en) Vascular anticoagulant proteins, dnas which code for them, manufacture and application thereof
ATE355295T1 (de) Synthese von oligosacchariden, reagenzien und verfahren
ATE179712T1 (de) Analoge für spezifische oligosaccharid-protein- wechselwirkungen und ihre verwendungen
DE3789676D1 (de) Diagnostisches Verfahren für Gonorrhoe durch Proben von IgA1-Fragmenten.
EP1019092A4 (de) Therapeutische und diagnostische mittel für krankheiten mit gestörter glukose-toleranz
CA2227491A1 (en) In situ preparation of nucleoside phosphoramidites and oligonucleotide synthesis
ID29565A (id) Terpolimer-terpolimer etilena dan proses pembuatannya
DE69009050D1 (de) Verfahren zur stabilisierung der hybridisierung von komplementären polynukleotidsequenzen.
WO1999016887A3 (en) Compositions and methods for identifying pkb kinase inhibitors
FI873674A0 (fi) -2-plasmin-inhibitorliknande protein kodande dna.
DE59502800D1 (de) Verfahren zur Erhöhung der Querbelastbarkeit von mechanischen Verbindungen
DE69110026D1 (de) Fertigungsverfahren für isothermische Zellen von Kühlfahrzeugen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties